Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
US Army
Deloitte
Healthtrust
Merck
Cantor Fitzgerald
Federal Trade Commission
Farmers Insurance

Generated: May 21, 2018

DrugPatentWatch Database Preview

Piperacetazine - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for piperacetazine and what is the scope of piperacetazine freedom to operate?

Piperacetazine
is the generic ingredient in one branded drug marketed by Dow Pharm and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for piperacetazine.
Summary for piperacetazine
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Bulk Api Vendors: 21
Patent Applications: 718
DailyMed Link:piperacetazine at DailyMed
Synonyms for piperacetazine
1-(10-(3-(4-(2-Hydroxyethyl)-1-piperidinyl)propyl)-10H-phenothiazin-2-yl)ethanone
1-(10-(3-[4-(2-Hydroxyethyl)-1-piperidinyl]propyl)-10H-phenothiazin-2-yl)ethanone #
1-(10-{3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl}-10H-phenothiazin-2-yl)ethanone
1-(10-{3-[4-(2-HYDROXYETHYL)PIPERIDIN-1-YL]PROPYL}-10H-PHENOTHIAZIN-2-YL)ETHAN-1-ONE
1-(10-{3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl}-10H-phenothiazin-2-yl)ethanone
1-[10-[3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl]-2-phenothiazinyl]ethanone
1-[10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]phenothiazin-2-yl]ethanone
10-(3-(4-(2-Hydroxyethyl)piperidino)propyl)phenothiazin-2-yl methyl ketone
2-Acetyl-10-(3-(4-(.beta.-hydroxyethyl)piperidino)propyl)phenothiazine
2-Acetyl-10-(3-(4-(beta-hydroxyethyl)piperidino)propyl)phenothiazine
3819-00-9
819P009
AB00514021
AB00514021_06
AC1L2EM8
AKOS030526141
API0009003
BPBio1_001074
BSPBio_000976
BTFMCMVEUCGQDX-UHFFFAOYSA-N
CAS-3819-00-9
CCG-213229
CHEBI:92293
CHEMBL1584
CS-4756
D02679
D0AO6B
DSSTox_CID_3481
DSSTox_GSID_23481
DSSTox_RID_77047
DTXSID7023481
EINECS 223-312-0
EN300-221562
Ethanone, 1-(10-(3-(4-(2-hydroxyethyl)-1-piperidinyl)propyl)-10H-phenothiazin-2-yl)-
Ethanone, 1-[10-[3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl]-10H-phenothiazin-2-yl]-
HMS1571A18
HMS2098A18
HMS2230G17
HMS3369H17
HY-B1152
Ketone, 10-(3-(4-(2-hydroxyethyl)piperidino)propyl)phenothiazin-2-yl methyl
KL6248WNW4
LS-87220
MLS002154124
MolPort-006-115-728
NCGC00016642-01
NCGC00016642-02
NCGC00016642-04
NCGC00179353-01
NSC-760067
NSC760067
PC-1421
Pharmakon1600-01503874
Piperacetazina
Piperacetazina [INN-Spanish]
Piperacetazine (USAN/INN)
Piperacetazine [USAN:INN]
Piperacetazine [USAN:USP:INN]
Piperacetazinum
Piperacetazinum [INN-Latin]
Piperazetazina
Piperazetazina [DCIT]
PL008285
PL055571
Prestwick0_001048
Prestwick1_001048
Prestwick2_001048
Prestwick3_001048
Psymod
Quide
Quide (TN)
SC 9794
SCHEMBL148569
SMR001233431
SPBio_002908
SR-01000841199
SR-01000841199-2
Tox21_110540
Tox21_110540_1
UNII-KL6248WNW4
Z2065671295
ZINC538186

US Patents and Regulatory Information for piperacetazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dow Pharm QUIDE piperacetazine TABLET;ORAL 013615-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dow Pharm QUIDE piperacetazine TABLET;ORAL 013615-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Julphar
Teva
UBS
Express Scripts
Harvard Business School
Cerilliant
Cantor Fitzgerald
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.